We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
Brief Study of Oppenheimer Value R Fund (CGRNX)
Oppenheimer Value R Fund (CGRNX - Free Report) seeks long-term growth of capital by investing primarily in common stocks with low price-earnings ratios and better-than-anticipated earnings. CGRNX invests mainly in common stocks of different capitalization ranges. CGRNX also can buy other investment including preferred stocks, rights and warrants and convertible debt securities, and securities of U.S. and foreign companies.
This Large Value product has a history of positive total returns for over 10 years. Specifically, the fund’s returns over the 3, 5 year benchmarks; 3 year 5.3% and 5 year 11.5%. To see how this fund performed compared in its category, and other #1 and #2 Ranked Mutual Funds, please click here.
The Oppenheimer Value R fund, as of the last filing, allocates their fund in top two major groups; Large Value and Large Growth. Further, as of the last filing, Bank of America Corporation, JPMorgan Chase & Co and Edison International were the top holdings for CGRNX.
This Zacks Rank #2 (Buy) was incepted in September 1985 and is managed by Oppenheimer. CGRNX carries an expense ratio of 1.21% and requires a minimal initial investment of $0.
Want key mutual fund info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>